マクロライドをはじめとする微生物由来生物活性天然物の合成研究と創薬展開
スポンサーリンク
概要
- 論文の詳細を見る
We have been working on finding new bioactive microbial metabolites at the Kitasato Institute. Their microbial natural products have a variety of unique and complex skeletones with many chiral centers and functional groups, and biological activities. We also have been working on synthetic study of them, which is effective and concise convergent approach, designed to afford easy access to both the natural products and a variety of analogs to clarify the structure-activity relationships.We have succeeded in the efficient total syntheses of bioactive microbial metabolites; pyripyropene (1), arisugacin (2), lactacystin (3), macrosphelide (4), and madindoline (5), and the construction of indoline spiroaminal moiety of neoxaline (6). We also have succeeded in creating better analogs of pyripyropene (1) and lactacystin (3).Furthermore, we have also been working on synthetic study of macrolides which have a variety of biological activities and also clarifying the mode of action in order to develop novel medicines. We have succeeded in creating novel macrolides, a motilide (EM574) and an anti-inflammatory agent (EM905).
- 2012-07-01
著者
関連論文
- P106 好酸球性副鼻腔炎におけるマクロライドEM900の有用性に関する検討(好酸球1,第20回日本アレルギー学会春季臨床大会)
- 244 好酸球性副鼻腔炎の鼻茸由来培養線維芽細胞に対するEM900の抗炎症作用(好酸球1,一般演題(デジタルポスター),第57回日本アレルギー学会秋季学術大会)
- 6 近未来のマクロライド誘導体の展望(3 上気道疾患のマクロライド療法, 第55回日本アレルギー学会秋季学術大会)
- マクロライド系薬の新作用と創薬
- S-5 和漢薬からのワクチンアジュバントの開発の試み
- マクロライドをはじめとする微生物由来生理活性物質の創薬に向けた合成研究
- グラム陰性病原細菌の有する宿主への感染過程に必須なIII型分泌機構を阻害するグアジノミン類の単離, 全合成および絶対立体配置決定
- マクロライドをはじめとする微生物由来生物活性天然物の合成研究と創薬展開